Archives
-
Demethyleneberberine: From Pathway to Phenotype
2026-09-10
Demethyleneberberine (DMB) is a mechanistically versatile research compound whose value lies in connecting pathway modulation with measurable cellular phenotypes. This guide shows how to select endpoints, controls, concentrations, and disease-model readouts for reproducible inflammation and NSCLC studies.
-
B. fragilis, Vagal Cholinergic Signaling, and Seizures
2026-09-09
Jia et al. identify a mechanistic gut–vagus–brain pathway through which Bacteroides fragilis suppresses seizures, linking colonic ChAT-positive cells, vagal transmission, and intestinal Lactobacillus enrichment. The study combines mouse circuit experiments with a pediatric randomized trial, providing a useful framework for evaluating microbiota-directed therapies in refractory epilepsy.
-
Cheminformatics Design of Optimized Small-Molecule Libraries
2026-09-09
Moret et al. introduce a data-driven framework for comparing and designing small-molecule collections using target coverage, binding selectivity, cellular phenotypes, chemical structure, clinical development status, and user preferences. Applied to kinase and mechanism-of-action libraries, the approach reduced redundant off-target activity while improving coverage, providing a practical foundation for more interpretable chemical-genetic experiments.
-
SGI-1027 Induces Apoptosis in Huh7 Cells
2026-09-08
The reference study shows that the non-nucleoside DNMT inhibitor SGI-1027 reduces Huh7 hepatocellular carcinoma cell viability primarily through apoptosis rather than detectable cell-cycle redistribution. Its integration of viability, flow cytometry, TUNEL staining, and BCL-2/BAX immunoblotting provides a useful framework for evaluating epigenetic anticancer mechanisms while highlighting the limits of extrapolating from one in vitro model.
-
T0070907: A Causal Test for PPARγ Signaling
2026-09-08
T0070907 is a high-affinity PPARγ antagonist for dissecting receptor-dependent transcription, adipogenesis, macrophage inflammation, and cancer-associated cell-cycle effects. This guide translates RXRα/PPARγ/NEDD4 findings into practical assay strategies while defining the compound’s limitations and controls.
-
Sphingosine-1-phosphate Assay Workflows
2026-09-07
Build receptor-aware S1P experiments that connect rapid signaling to endothelial behavior and neuronal apoptosis. This practical workflow combines fresh-solution handling, dose–time design, orthogonal controls, and troubleshooting for more reproducible vascular and cell-death assays.
-
URB597 and the Translational Logic of FAAH Inhibition
2026-09-07
URB597 (KDS-4103) offers a selective way to interrogate FAAH-dependent anandamide biology. By connecting precise target engagement with recent findings in inflammatory pain, this article outlines how researchers can use URB597 to strengthen neuroinflammation, neuroplasticity, and translational endocannabinoid studies without overinterpreting pharmacology.
-
Candida krusei Apoptosis Pathways in Bovine Cells
2026-09-05
The reference study shows that Candida krusei yeast and hypha phases both induce apoptosis in bovine mammary epithelial cells, but they preferentially engage different signaling routes. Its comparative co-culture design links the yeast phase to mitochondrial apoptosis and the hypha phase to death ligand/receptor signaling, providing a framework for phase-specific mastitis research.
-
PARP7–STAT1/2 Control in EAE
2026-09-04
Xu et al. show that PARP7 suppresses type I interferon signaling by ADP-ribosylating STAT1 and STAT2, promoting their ubiquitination and p62-dependent autophagic degradation. Inhibition of PARP7 restored interferon pathway activity and reduced experimental autoimmune encephalomyelitis in mice, identifying a mechanistic link with potential relevance to multiple sclerosis research.
-
Prednisone Assay Design: From Cells to Digestion
2026-09-04
Prednisone research is strongest when cell state, solvent handling, and endpoint selection are treated as one experimental system. This article connects lymphocyte mechanism with a metabolomics-inspired framework for more reproducible immunology and translational assays.
-
LNP Circular IL-23 mRNA Boosts MSA-2 Therapy
2026-09-03
The 2025 Materials Today Bio study combines an optimized lipid nanoparticle carrying circular IL-23 mRNA with platinum-modified MSA-2 to strengthen local STING-based melanoma immunotherapy. Its intratumoral combination strategy produced tumor cell death, immune activation, reduced B16F10 tumor burden, and longer survival, while highlighting formulation and route as major determinants of mRNA therapeutic performance.
-
AG-126: Practical ERK Pathway Research Workflows
2026-09-03
AG-126 offers a practical way to interrogate ERK1/2 phosphorylation, cytokine signaling, and pathway-dependent phenotypes across cell-based assays. This guide connects validated inflammatory use cases with a carefully bounded neuroscience application inspired by Neuroligin 1 and striatal D2-MSN research.
-
CXCR4 Theranostics in Lymphoma: Evidence and Limits
2026-09-02
The 2026 review by Dhamecha and colleagues positions CXCR4 as a biologically relevant bridge between lymphoma imaging, disease characterization, and targeted therapy. Its main contribution is an integrated comparison of peptide and small-molecule imaging ligands with radioligand, antagonist, and antibody-based interventions, while emphasizing physiological uptake, receptor heterogeneity, and CXCR7 compensation as barriers to translation.
-
Fluconazole: A Systems View of Biofilm Resistance
2026-09-02
Fluconazole can do more than benchmark fungal growth inhibition: it can help connect ergosterol stress with biofilm physiology and antifungal drug resistance. This article translates PP2A–autophagy findings into a mechanistically resolved assay strategy for Candida research.
-
Aprotinin in GRO-seq Workflow Design
2026-09-01
Aprotinin adds a defined, reversible serine-protease control to nuclei-based workflows without pretending to replace RNase protection or the validated GRO-seq chemistry. This guide translates the rRNA-depleted wheat GRO-seq method into practical pilot designs for protease-sensitive sample preparation, fibrinolysis studies, and inflammatory assay troubleshooting.